Empatab 10mg Tablet 10pcs

Uses of Empatab 10mg Tablet

Type 2 diabetes mellitus

How does Empatab 10mg Tablet work?

Empatab 10 blocks the sodium-glucose co-transporter-2 (SGLT-2) enzyme in the kidney's proximal tubules. It lowers renal reabsorption of glucose and increases urine excretion of glucose via inhibiting SGLT2. As a result, it lowers blood sugar levels in diabetics.

Side Effects of Empatab 10mg Tablet

Common adverse reactions include urinary tract infections, female genital mycotic infections, dehydration, hypotension, weakness, dizziness, and increased thirst.

Quick Suggestions:

• This medication may cause your body to lose too much fluid (dehydration) or increase urination frequency. Ensure adequate hydration by drinking plenty of water.
• Be aware of the risk of hypoglycemia (low blood sugar) when using Empatab 10 with other antidiabetic medications, alcohol, or in case of delayed or missed meals. Always carry sugary foods or fruit juice to address hypoglycemia symptoms promptly.
• Empatab 10 may increase the risk of genital fungal and urinary tract infections in both males and females. Maintain good hygiene practices to minimize the risk of infections.
• Monitor your blood sugar levels regularly while taking Empatab 10 to ensure optimal control and adjust treatment as needed.
• Inform your doctor immediately if you experience persistent dizziness, joint pain, symptoms resembling a cold, or unexplained nausea/vomiting while taking Empatab 10.

Indication of Empatab 10mg Tablet

Empatab 10mg Tablet plays a vital role in managing diabetes and achieving good control of blood sugar levels by delaying the absorption of sugar and increasing insulin sensitivity in the body.

Pharmacology of Empatab 10mg Tablet

Empagliflozin acts as a sodium-glucose co-transporter-2 (SGLT-2) inhibitor. SGLT2 co-transporters facilitate glucose reabsorption from the kidney filtrate. Inhibiting SGLT2 reduces renal glucose absorption, lowers the renal threshold for glucose, increases glucose excretion, and contributes to reduced hyperglycemia, weight loss, and decreased blood pressure.

Dosage & Administration of Empatab 10mg Tablet

The recommended dose is 10 mg once daily, in the morning, with or without food. If tolerated, the dose may be increased to 25 mg once daily. Correcting volume depletion before initiating Empagliflozin is recommended. 

In case of overdose, supportive measures should be employed. Empagliflozin removal by hemodialysis has not been studied.

Interaction

Empagliflozin may interact with diuretics, insulin, or insulin secretagogues, potentially increasing urine volume or the risk of hypoglycemia. It also affects urine glucose tests and 1,5-anhydroglucitol (1,5-AG) assay reliability.

Contraindications

Empagliflozin is contraindicated in patients with severe hypersensitivity reactions to the drug or its components, severe renal impairment, end-stage renal disease, or undergoing dialysis.

Pregnancy & Lactation

Use during pregnancy is only recommended if the potential benefit justifies the potential risk to the fetus. It is not recommended during breastfeeding due to unknown excretion in human milk.

Precautions & Warnings

Renal function should be assessed before initiating Empagliflozin and periodically thereafter. It should not be initiated if eGFR is less than 45 ml/min/1.73 m2.

Storage Conditions:

Store below 30°C in a cool, dry place, protected from light and moisture, and keep out of the reach of children.